Inventor
LAURENS KRUIDENIER
Inventor
US
Overview
Patents· 3 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C07KPeptides25%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms25%
PatentTitleYear
12,391,752Methods of enriching or amplifying nucleic acids in a sample from a patient with inflammatory bowel disease202512,215,147Methods of selecting, based on polymorphisms, an inflammatory bowel disease subject for treatment with an anti-TL1A antibody202511,136,386Methods of treating Crohn's disease or ulcerative colitis by administering inhibitors of tumor necrosis factor-like cytokine 1A (TL1A)2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to CEDARS SINAI MEDICAL CENTER (3)· patent assignee history
2021–2025Patents assigned to PROMETHEUS BIOSCIENCES INC (3)· patent assignee history
2021–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CEDARS SINAI MEDICAL CENTER | 3 | 2021–2025 |
| PROMETHEUS BIOSCIENCES INC | 3 | 2021–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 3 | 2021–2025 |